Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis

S. J. Wang*, J. L. Lan, J. L. Lan, D. Y. Chen, Y. H. Chen, T. Y. Hsieh, W. Y. Lin

*此作品的通信作者

研究成果: Article同行評審

25 引文 斯高帕斯(Scopus)

摘要

In most patients with progressive systemic sclerosis (PSS) the oesophagus is affected. Reflux symptoms are most frequent, whilst dysphagia also occurs. Cisapride, a prokinetic agent, may enhance motility along the gastrointestinal tract. The effects of cisapride on oesophageal transit were evaluated in 12 PSS patient using a solid-phase radionuclide oesophageal transit study. Each PSS patient was given cisapride 10 mg or placebo orally three times a day in a random, double-blind, crossover fashion. The results show that cisapride does not seem to have any impact on oesophageal transit in patients with PSS.

原文English
頁(從 - 到)43-45
頁數3
期刊Clinical Rheumatology
21
發行號1
DOIs
出版狀態Published - 2002

指紋

深入研究「Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis」主題。共同形成了獨特的指紋。

引用此